Evidence map›Paper›PMID 34185046›Full record

ArticleJAMA cardiology2021

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.

Han W Kim, Elizabeth R Jenista, David C Wendell, Clerio F Azevedo, Michael J Campbell, Stephen N Darty, Michele A Parker, Raymond J Kim

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in JAMA cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 216 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
216citing papers in PubMed, 13 pooled it
51.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

216 citing papers in PubMed, 13 syntheses or guidelines pooled it, 346 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. "Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era".International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

156 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Han W KimDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Elizabeth R JenistaDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
David C WendellDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Clerio F AzevedoDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Michael J CampbellDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Stephen N DartyDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Michele A ParkerDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Raymond J KimDuke Cardiovascular Magnetic Resonance Center, Durham, North Carolina.
Duke Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Vaccine-associated myocarditis is an unusual entity that has been described for the smallpox vaccine, but only anecdotal case reports have been described for other vaccines. Whether COVID-19 vaccination may be linked to the occurrence of myocarditis is unknown. Objective: To describe a group of 7 patients with acute myocarditis over 3 months, 4 of whom had recent messenger RNA (mRNA) COVID-19 vaccination. Design, Setting, and Participants: All patients referred for cardiovascular magnetic resonance imaging at Duke University Medical Center were asked to participate in a prospective outcomes registry. Two searches of the registry database were performed: first, to identify patients with acute myocarditis for the 3-month period between February 1 and April 30 for 2017 through 2021, and second, to identify all patients with possible vaccine-associated myocarditis for the past 20 years. Once patients with possible vaccine-associated myocarditis were identified, data available in the registry were supplemented by additional data collection from the electronic health record and a telephone interview. Exposures: mRNA COVID-19 vaccine. Main Outcomes and Measures: Occurrence of acute myocarditis by cardiovascular magnetic resonance imaging. Results: In the 3-month period between February 1 and April 30, 2021, 7 patients with acute myocarditis were identified, of which 4 occurred within 5 days of COVID-19 vaccination. Three were younger male individuals (age, 23-36 years) and 1 was a 70-year-old female individual. All 4 had received the second dose of an mRNA vaccine (2 received mRNA-1273 [Moderna], and 2 received BNT162b2 [Pfizer]). All presented with severe chest pain, had biomarker evidence of myocardial injury, and were hospitalized. Coincident testing for COVID-19 and respiratory viruses provided no alternative explanation. Cardiac magnetic resonance imaging findings were typical for myocarditis, including regional dysfunction, late gadolinium enhancement, and elevated native T1 and T2. Conclusions and Relevance: In this study, magnetic resonance imaging findings were found to be consistent with acute myocarditis in 7 patients; 4 of whom had preceding COVID-19 vaccination. Further investigation is needed to determine associations of COVID-19 vaccination and myocarditis.

Indexed as

2019-nCoV Vaccine mRNA-1273Acute DiseaseAdultAgedBNT162 VaccineCardiac Imaging TechniquesChest PainCOVID-19COVID-19 VaccinesFemaleGadoliniumHospitalizationHumansMagnetic Resonance ImagingMaleMyocarditis2019-nCoV Vaccine mRNA-1273BNT162 VaccineCOVID-19 VaccinesGadolinium

Identifiers

PMID34185046
PMCPMC8243258
OpenAlexW3176051599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.